RMTG unit ISSCA launches longevity, adjunctive therapies certification program
RMTG•Regenerative Medical Technology Group launched an ISSCA certification program for physicians in longevity-focused practices, covering training in plasma exchange, peptide medicine, IV therapy, AI tools and device-based therapies.
1. Certification program
The program is positioned as an education product, not confirmation that all covered therapies are offered at the company’s Cellular Hope Institute clinic.
